The 3 Keys to Unlocking Scalable HCP Engagement

Reaching healthcare providers (HCPs) at scale is one of the most complex challenges in healthcare advertising. Unlike broad consumer audiences, effectively engaging HCPs requires precise targeting based on their specialties, prescribing behaviors, and real-world activity. 

As healthcare advertising evolves, so does the need for more sophisticated, data-driven solutions. The future lies in empowering marketers with greater data choice, transparency, and scale.

This article explores the key elements that drive smarter HCP engagement and how DeepIntent’s latest platform updates are addressing these needs. We’ll dive into the importance of data choice, AI-driven optimization, and the role of a comprehensive HCP identity graph in maximizing reach, accuracy, and campaign performance.

 

Expanding Data Choice for Smarter Healthcare Advertising

Historically, advertisers have had limited transparency and flexibility when selecting health data sources for programmatic campaigns. Many platforms obscure their data sources or lock advertisers into a single provider, even when another may offer better coverage for their needs. This lack of choice restricts advertisers’ ability to scale connections with relevant HCP audiences. Luckily, this is changing. Data flexibility is the future, giving marketers greater control to scale reach and drive smarter results.

At DeepIntent, we believe advertisers should have the power to choose the best health data for their campaigns. That’s why we’ve adopted a marketplace approach, fully integrating Symphony Health and IQVIA across our Health Intelligent product suite to deliver unmatched choice, transparency, and scale.

One way advertisers are already benefiting from this is through HCP Planner. With multiple data sources now integrated, advertisers can explore insights across datasets and select the most relevant information to align with their brand’s needs and campaign goals. This enhanced flexibility empowers healthcare advertisers to make more informed decisions, driving stronger HCP engagement across premium media and channels.

AI-Powered Recommendations to Optimize HCP Reach

Another benefit to a platform that fully integrates multiple health data sources is the ability to use  AI-driven audience recommendations to expand HCP reach. Traditionally, achieving the right balance between reach and precision has been a manual, time-consuming process, requiring frequent audience refinements and campaign adjustments. This slows execution and limits both performance and scale.

To streamline this process, DeepIntent Copilot, our Health Intelligent recommendation tool, now evaluates HCP audiences across multiple datasets and automatically identifies opportunities to expand reach by suggesting additional segments. By simply clicking the “Optimize Reach” button next to HCP audiences, advertisers can view these recommendations and enhance their targeting instantly. 

This seamless, one-click optimization feature allows advertisers to scale campaigns effortlessly, ensuring that both reach and performance are continuously optimized.

 

The Benefits of a Specialized HCP Identity Graph

Scaling reach to the right HCPs requires precise identity resolution that goes beyond standard digital identifiers. Unlike consumer segments, HCPs are highly specialized and depend on verified National Provider Identifiers (NPIs)—a vital reference often missing from generic identity graphs.

A specialized HCP graph consolidates multiple digital identities into a single, verified HCP profile using NPIs and other healthcare-specific data signals. Unlike broad consumer identity graphs, an HCP graph is purpose-built for healthcare marketing, ensuring greater accuracy, compliance, and omnichannel HCP reach.

DeepIntent’s proprietary HCP Identity Graph takes this a step further by bridging health and media data, enabling advertisers to reach over 3.4 million opted-in, addressable HCPs. Built from high-quality healthcare datasets and based on opted-in consented data, it ensures scaled, privacy-compliant reach across devices.

Our graph connects each NPI to seven digital identifiers, providing:

  • Broader reach by expanding access to more verified HCPs across specialties and channels.
  • Higher match rates, seamlessly linking offline clinical data to digital identities.
  • Scaled omnichannel activation across channels, including CTV and endemic media.
  • Privacy-safe data that ensures compliance while delivering scaled, high-quality engagement.
  • Future-proof targeting not reliant on cookie-based identifiers.

 

With DeepIntent’s HCP Identity Graph, advertisers can confidently expand HCP reach while maintaining accuracy and compliance, leading to stronger engagement, better campaign performance, and greater impact on healthcare outcomes.

 

Conclusion

Scaling smarter HCP engagement requires the right combination of data choice, AI-powered optimization, and a specialized HCP identity graph. By prioritizing these elements, advertisers can break through data fragmentation, enhance targeting accuracy, and drive meaningful engagement with healthcare professionals. As the healthcare advertising landscape evolves, solutions that offer transparency, automation, and precision will be critical in ensuring successful outcomes.

DeepIntent remains committed to empowering advertisers with innovative tools and data-driven strategies that maximize reach while maintaining compliance and efficiency. The future of HCP engagement is here—smarter, scalable, and more effective than ever before.

Share this Post

Related Articles

Despite years of progress in healthcare innovation, too many patients in North America still face barriers to care that stem not from biology, but from geography, income, and systemic inequities. Across North America, millions of people live in “care deserts” with limited or no access to hospitals, pharmacies, or primary care providers. These individuals, many […]

Last week, Cannes Lions 2025 brought together the global advertising industry for a week of high-profile programming, creative celebration, and perhaps most importantly, meaningful connection. Panels offered insight into where marketing is headed, and other insights emerged among leaders between sessions. Here are six key takeaways that reflect the shifting priorities, new challenges, and emerging […]

Last week, a new bill called the “End Prescription Drug Ads Now Act” was introduced in Congress, aiming to ban nearly all direct-to-consumer (DTC) pharmaceutical advertising. While the legislation has sparked headlines, its chances of becoming law are slim due to constitutional concerns and bipartisan disagreement. Still, it reflects growing attention to the pharmaceutical industry […]

Never Miss New Insights

Sign up for the newsletter to ensure our latest whitepapers, research reports, and more are delivered to your inbox.